Ironwood Pharmaceuticals (IRWD) Total Current Liabilities (2010 - 2026)

Ironwood Pharmaceuticals has reported Total Current Liabilities for 17 years, with the latest figure at $236.3 million in Q1 2026.

• Quarterly Total Current Liabilities rose 391.31% year-over-year to $236.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $236.3 million (up 391.31% YoY) and the FY2025 annual result came in at $242.2 million, up 523.53% from the prior year.
• Total Current Liabilities eased to $236.3 million in Q1 2026 per IRWD's latest filing, from $242.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $305.4 million in Q2 2023 and troughed at $23.3 million in Q2 2022.
• A 5-year average of $146.9 million and a median of $147.4 million in 2022 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities jumped 1210.8% in 2023, then slumped 85.93% in 2024.
• Over 5 years, Total Current Liabilities stood at $25.5 million in 2022, then jumped by 981.69% to $276.1 million in 2023, then plunged by 85.93% to $38.8 million in 2024, then surged by 523.53% to $242.2 million in 2025, then decreased by 2.44% to $236.3 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $236.3 million, $242.2 million, and $242.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.